Allergy Treatment Market by Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, and Other Allergies), Treatment (Anti-Allergy Medicine and Immunotherapy) and End User (Hospital, Clinics, Pharmacy, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025". The report presents comprehensive analyses of the global market by analyzing the market dynamics, top investment pockets, key player positioning, and competitive landscape. According to the report, the global allergy treatment market garnered $24.65 billion in 2017 and is expected to reach $40.36 billion by 2025, registering CAGR of 6.3% from 2018 to 2025.
Get Free Sample PDF of Market:
https://www.alliedmarketresearch.com/request-sample/3541
Allergies are defined as hypersensitive reactions to foreign substances by the immune system. The things that cause allergies are called allergens. Examples include pollens, brown hair, mold, pet dander, certain foods and others. Patients with frequent allergies are said to be allergic or atopic. The allergy treatment market is expected to grow rapidly due to the focus on the development of new treatments for specific drugs, the advent of immunotherapy and the increase in allergies in the world.
Major Key market players -
GlaxoSmithKline,
Allergopharma,
Allergan, Inc.,
Schering-Plough Corporation,
Collegium Pharmaceutical, Inc.,
Allergy therapeutics,
Allergon,
Genentech Inc.,
McNeil Consumer Healthcare, and
Meda Pharmaceuticals, Inc.
For Purchase Inquiry of Market Report:
https://www.alliedmarketresearch.com/purchase-enquiry/3541
By type, the rhinitis segment generated the highest revenue in 2017 and is expected to retain this dominance during the forecast period. This is due to the increase in allergic rhinitis worldwide. For example, according to the European Academy of Allergy and Clinical Immunology (EAACI), about 400 million people suffer from rhinitis. However, the food allergy segment is expected to register the highest growth rate during the forecast period.
North America was the largest contributor to the global market in 2017, with increased investment in the health of manufacturers, increased R&D funding for the development of treatments for allergies and an increase in -increased incidence of food allergies. Asia-Pacific is expected to witness the highest growth rate during the forecast period, due to the increase in the prevalence of asthma due to the increase in pollution, increasing internet and awareness of the disease.
Buy Now with Discount (Till 15th January 2023):
https://www.alliedmarketresearch.com/checkout-final/9d7f9fd55aedf1cac8cc790061981aec
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285
+1-503-894-6022
+1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
